VECTAVIR

This brand name is authorized in Finland, Ireland, New Zealand, Turkey

Active ingredients

The drug VECTAVIR contains one active pharmaceutical ingredient (API):

1 Penciclovir UNII 359HUE8FJC - PENCICLOVIR

Penciclovir has demonstrated in vivo and in vitro activity against herpes simplex viruses (types 1 and 2) and varicella zoster virus. Penciclovir triphosphate persists in infected cells for more than 12 hours where it inhibits replication of viral DNA and has a half-life of 9, 10 and 20 hours in cells infected with varicella zoster virus, herpes simplex virus type 1 and herpes simplex virus type 2 respectively. Read about Penciclovir

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
VECTAVIR Cream	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D06BB06	Penciclovir	D Dermatologicals → D06 Antibiotics and chemotherapeutics for dermatological use → D06B Chemotherapeutics for topical use → D06BB Antivirals
Discover more medicines within D06BB06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 399782
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 7599
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8692255002186